摘要
Soluble beta-amyloid (A尾) oligomers are considered to putatively play a critical role in the early synapse loss and cognitive impairment observed in Alzheimer's disease. We previously demonstrated that A尾 oligomers activate cytosolic phospholipase A2 (cPLA2), which specifically releases arachidonic acid from membrane phospholipids. We here observed that cPLA2 gene inactivation prevented the alterations of cognitive abilities and the reduction of hippocampal synaptic markers levels noticed upon a single intracerebroventricular injection of A尾 oligomers in wild type mice. We further demonstrated that the A尾 oligomer-induced sphingomyelinase activation was suppressed and that phosphorylation of Akt/protein kinase B (PKB) was preserved in neuronal cells isolated from cPLA2鈭?鈭?/sup> mice. Interestingly, expression of the A尾 precursor protein (APP) was reduced in hippocampus homogenates and neuronal cells from cPLA2鈭?鈭?/sup> mice, but the relationship with the resistance of these mice to the A尾 oligomer toxicity requires further investigation. These results therefore show that cPLA2 plays a key role in the A尾 oligomer-associated neurodegeneration, and as such represents a potential therapeutic target for the treatment of Alzheimer's disease.